{"instruction": "You are an expert in event extraction. Please extract events from the input that conform to the schema definition. Return an empty list for events that do not exist, and return NAN for arguments that do not exist. If an argument has multiple values, please return a list. Respond in the format of a JSON string.", "schema": [{"event_type": "adverse event", "trigger": true, "arguments": ["Treatment.Freq", "Effect", "Subject.Gender", "Combination.Drug", "Treatment.Route", "Treatment.Time_elapsed", "Subject.Race", "Treatment.Disorder", "Subject.Age", "Subject.Disorder", "Treatment.Dosage", "Subject", "Treatment.Duration"]}, {"event_type": "potential therapeutic event", "trigger": true, "arguments": ["Combination.Drug", "Subject.Disorder", "Treatment.Drug", "Effect", "Treatment.Duration", "Treatment.Disorder", "Subject.Race", "Subject", "Treatment.Route", "Treatment", "Treatment.Freq", "Treatment.Dosage", "Subject.Age", "Subject.Gender", "Subject.Population", "Treatment.Time_elapsed"]}], "input": "A phase III trial, Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors (CATAPULT I), was designed to determine the efficacy and safety of tirapazamine plus cisplatin for the treatment of non-small-cell lung cancer (NSCLC)."}
{"adverse event": [], "potential therapeutic event": [{"trigger": "treatment ", "arguments": {"Combination.Drug": ["tirapazamine", "cisplatin"], "Subject.Disorder": "NAN", "Treatment.Drug": ["tirapazamine", "cisplatin"], "Effect": "NAN", "Treatment.Duration": "NAN", "Treatment.Disorder": "non-small-cell lung cancer (NSCLC)", "Subject.Race": "NAN", "Subject": "NAN", "Treatment.Route": "NAN", "Treatment": "tirapazamine plus cisplatin", "Treatment.Freq": "NAN", "Treatment.Dosage": "NAN", "Subject.Age": "NAN", "Subject.Gender": "NAN", "Subject.Population": "NAN", "Treatment.Time_elapsed": "NAN"}}]}